| William Gage Liesman, MD | |
|
4304 Andrews Hwy, Midland, TX 79703-4824 | |
| (432) 520-3020 | |
| (432) 699-1981 |
| Full Name | William Gage Liesman |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 11 Years |
| Location | 4304 Andrews Hwy, Midland, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144665233 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | Q9663 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midland Memorial Hospital | Midland, TX | Hospital |
| Reeves County Hospital District | Pecos, TX | Hospital |
| Pecos County Memorial Hospital | Fort stockton, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dora Roberts Rehabilitation Center | 0941285498 | 65 |
| Urgent Orthopedic Specialists Pllc | 1951546001 | 8 |
News Archive
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that its upcoming conference call on its third quarter financial results will also provide some representative examples of data being collected from patients in its clinical trials for forms of macular degeneration.
In a new study, scientists at The Scripps Research Institute have identified drug candidates that can boost a cell's ability to catch the "typos" in protein production that can cause a deadly disease called amyloidosis.
Onyx Pharmaceuticals, Inc. today announced that it will delay its New Drug Application (NDA) filing for carfilzomib based on a recent meeting with the Chemistry, Manufacturing and Controls (CMC) review division of the U.S. Food and Drug Administration (FDA).
According to the news service, WHO "members … raised strong concerns that a working group they mandated last May to address problems with WHO policy on counterfeit and substandard medicines has yet to be formed - with four months remaining before it must report back to members."
› Verified 3 days ago
| Entity Name | Urgent Orthopedic Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215271929 PECOS PAC ID: 1951546001 Enrollment ID: O20130321000052 |
News Archive
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that its upcoming conference call on its third quarter financial results will also provide some representative examples of data being collected from patients in its clinical trials for forms of macular degeneration.
In a new study, scientists at The Scripps Research Institute have identified drug candidates that can boost a cell's ability to catch the "typos" in protein production that can cause a deadly disease called amyloidosis.
Onyx Pharmaceuticals, Inc. today announced that it will delay its New Drug Application (NDA) filing for carfilzomib based on a recent meeting with the Chemistry, Manufacturing and Controls (CMC) review division of the U.S. Food and Drug Administration (FDA).
According to the news service, WHO "members … raised strong concerns that a working group they mandated last May to address problems with WHO policy on counterfeit and substandard medicines has yet to be formed - with four months remaining before it must report back to members."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Gage Liesman, MD 4304 Andrews Hwy, Midland, TX 79703-4824 Ph: (432) 520-3020 | William Gage Liesman, MD 4304 Andrews Hwy, Midland, TX 79703-4824 Ph: (432) 520-3020 |
News Archive
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that its upcoming conference call on its third quarter financial results will also provide some representative examples of data being collected from patients in its clinical trials for forms of macular degeneration.
In a new study, scientists at The Scripps Research Institute have identified drug candidates that can boost a cell's ability to catch the "typos" in protein production that can cause a deadly disease called amyloidosis.
Onyx Pharmaceuticals, Inc. today announced that it will delay its New Drug Application (NDA) filing for carfilzomib based on a recent meeting with the Chemistry, Manufacturing and Controls (CMC) review division of the U.S. Food and Drug Administration (FDA).
According to the news service, WHO "members … raised strong concerns that a working group they mandated last May to address problems with WHO policy on counterfeit and substandard medicines has yet to be formed - with four months remaining before it must report back to members."
› Verified 3 days ago
John Dean, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5615 Deauville Blvd, Ste 220, Midland, TX 79706 Phone: 432-686-0321 Fax: 432-686-0664 | |
Dr. Franklin J Dzida, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5615 Deauville Blvd, Ste 220, Midland, TX 79706 Phone: 432-686-0321 Fax: 432-686-0664 | |
Mr. Charles M Younger, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2000 W Cuthbert Ave, Midland, TX 79701 Phone: 432-684-5848 Fax: 432-684-8017 | |
Dr. Jessie James Dickens, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5615 Deauville Blvd, Ste 220, Midland, TX 79706 Phone: 432-686-0321 Fax: 432-686-0664 | |
Dr. David J Mallams, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 5615 Deauville Blvd, Ste 220, Midland, TX 79706 Phone: 432-686-0321 Fax: 432-686-0664 | |
David Hamilton Macdonald, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4304 Andrews Hwy, Midland, TX 79703 Phone: 432-520-3020 |